IA
RGNX icon

Inspire Advisors’s Regenxbio RGNX Stock Holding History

Inspire Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22,606
Closed -$372K – 367
2023
Q3 		$372K Sell
22,606
-22,847
-50% -$414K 0.07% 164
2023
Q2 		$909K Buy
45,453
+5,364
+13% +$103K 0.18% 49
2023
Q1 		$758K Buy
+40,089
New +$887K 0.17% 50

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Inspire Advisors's RGNX Position: Q4 2023 in Review

Inspire Advisors sold out of Regenxbio (RGNX) in Q4 2023, closing a stake of 22,606 shares — an estimated $372K sold.

Inspire Advisors first reported a position in RGNX in Q1 2023 and held it in 3 quarters. The position peaked at $909K in Q2 2023. 171 funds tracked by Wall St. Rank hold RGNX as of Q4 2023.

  • Inspire Advisors reported no remaining Regenxbio position as of Q4 2023 after selling out during the quarter.
  • Inspire Advisors sold 22,606 Regenxbio shares in Q4 2023, an estimated $372K.
  • Inspire Advisors first reported a position in Regenxbio in Q1 2023 and held it in 3 quarters.
  • Inspire Advisors's Regenxbio position peaked at $909K in Q2 2023.
  • 171 funds tracked by Wall St. Rank held Regenxbio as of Q4 2023.

Based on Inspire Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.